Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre

被引：0
|
作者：
Chiara Catania
Gilda Ascione
Laura Adamoli
Tommaso De Pas
Marta Medici
Lucia Franceschelli
Elena Verri
Elena Magni
Giuseppina Sanna
Rosalba Torrisi
Aron Goldhirsch
Franco Nolè
机构：
[1] European Institute of Oncology,Unit for Medical Care, Division of Medical Oncology
[2] European Institute of Oncology,New Drugs Development Division
[3] European Institute of Oncology,Research Unit of Medical Senology
[4] European Institute of Oncology,Department of Medicine
来源：
Breast Cancer Research and Treatment | 2007年 / 106卷
关键词：
Breast cancer; Endocrine treatment; Fulvestrant; Postmenopausal;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 103
页数：6
相关论文
共 50 条
  • [31] Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
    Cabel, Luc
    Carton, Matthieu
    Cheaib, Bianca
    Pierga, Jean-Yves
    Dalenc, Florence
    Mailliez, Audrey
    Levy, Christelle
    Jacot, William
    Debled, Marc
    Leheurteur, Marianne
    Desmoulins, Isabelle
    Lefeuvre, Claudia
    Goncalves, Anthony
    Uwer, Lionel
    Ferrero, Jean-Marc
    Eymard, Jean-Christophe
    Petit, Thierry
    Mouret-Reynier, Marie-Ange
    Perrocheau, Genevieve
    Piot, Irwin
    Perol, David
    Simon, Gaetane
    Lerebours, Florence
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (02) : 397 - 406
  • [32] Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
    Luc Cabel
    Matthieu Carton
    Bianca Cheaib
    Jean-Yves Pierga
    Florence Dalenc
    Audrey Mailliez
    Christelle Levy
    William Jacot
    Marc Debled
    Marianne Leheurteur
    Isabelle Desmoulins
    Claudia Lefeuvre
    Anthony Gonçalves
    Lionel Uwer
    Jean-Marc Ferrero
    Jean-Christophe Eymard
    Thierry Petit
    Marie-Ange Mouret-Reynier
    Geneviève Perrocheau
    Irwin Piot
    David Pérol
    Gaëtane Simon
    Florence Lerebours
    Breast Cancer Research and Treatment, 2019, 173 : 397 - 406
  • [33] Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents
    Agrawal A.
    Robertson J.F.R.
    Cheung K.L.
    World Journal of Surgical Oncology, 4 (1)
  • [34] Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective study.
    Jagiello-Gruszfeld, Agnieszka I.
    Meluch, Malgorzata
    Kunkiel, Michal
    Gorniak, Anna
    Majstrak-Hulewska, Anna
    Gorska, Katarzyna
    Konieczna, Aleksandra
    Nowecki, Zbigniew
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Plerixafor plus G-CSF can mobilize autologous haematopoietic stem cells from heavily pre-treated patients failing previous mobilization attempts: analysis of the French compassionate use programme
    Mohty, M.
    Lefrere, F.
    Caillot, D.
    Azar, N.
    Miclea, J. M.
    Broussais, F.
    Marolleau, J. P.
    Attal, M.
    Milpied, N.
    Gisselbrecht, C.
    Moreau, P.
    Chabannon, C.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S319 - S320
  • [36] Combination chemotherapy with Cisplatin, etoposide, and ifosfamide as a salvage treatment in heavily pre-treated metastatic breast cancer patients
    Habbel, P.
    Kurreck, A.
    Schulz, C. -O.
    Neumann, C.
    Possinger, K.
    Eucker, J.
    ONKOLOGIE, 2013, 36 : 160 - 160
  • [37] Weekly Non-pegylated Liposomal Doxorubicin Chemotherapy in Heavily Pre-treated Patients with Metastatic Breast Cancer
    Masci, Giovanna
    Gandini, Chiara
    Zuradelli, Monica
    Losurdo, Agnese
    Torrisi, Rosalba
    Rota, Selene
    Gullo, Giuseppe
    Velutti, Laura
    Giordano, Laura
    Santoro, Armando
    ANTICANCER RESEARCH, 2013, 33 (10) : 4603 - 4609
  • [38] Fulvestrant in heavily pretreated patients with advanced breast cancer: A Belgium cooperative study.
    Neven, P.
    Paridaens, R.
    Pelgrims, G.
    Martens, M.
    Bols, A.
    Goeminne, J. C.
    Vindevoghel, A.
    Demol, J.
    Stragier, B.
    De Greve, J.
    Schallier, D.
    Van Den Weyngaert, D.
    Becquart, D.
    Borms, M.
    Cocquyt, V
    Van Den Broecke, R.
    Selleslags, J.
    Awada, A.
    Dirix, L.
    Van Dam, P.
    Azerad, M. A.
    Vandenhoven, G.
    Christianes, M. R.
    Vergote, I
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S195 - S195
  • [39] Capecitabine monotherapy in pre-treated patients with metastatic breast cancer
    Gennatas, Constantine
    Michalaki, Vasiliki
    Psychogios, John
    Kairi-Vasilatou, E.
    Karvouni, Helen
    Kondi-Paphiti, Agathi
    ANNALS OF ONCOLOGY, 2006, 17 : 86 - 86
  • [40] A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer
    Hu, Nanlin
    Zhu, Anjie
    Si, Yiran
    Yue, Jian
    Wang, Xue
    Wang, Jiayu
    Ma, Fei
    Xu, Binghe
    Yuan, Peng
    FRONTIERS IN ONCOLOGY, 2021, 10
12345